Effect of Sevelamer on P-cresyl Sulfate in CKD

Trial Profile

Effect of Sevelamer on P-cresyl Sulfate in CKD

Phase of Trial: Phase III

Latest Information Update: 28 Feb 2017

At a glance

  • Drugs Sevelamer (Primary)
  • Indications Hyperphosphataemia; Renal failure
  • Focus Therapeutic Use
  • Most Recent Events

    • 23 Feb 2015 Planned primary completion date changed from 1 Nov 2014 to 1 May 2015 as reported by ClinicalTrials.gov record.
    • 29 Oct 2014 Design changed from open to randomizes, single blind, parallel; single arm to 2 arms; inclusion/ exclusion criterion changed; second arm is continuously changing between no arm to calcium carbonate, now it is placebo.
    • 01 Sep 2014 According to the ClinicalTrials.gov record, planned end date changed to 1 Nov 2014.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top